Furthermore, genetic variation of SLCO2B1 is associated with resistance to androgen deprivation therapy as well as OS of PCa, whereas there was no difference in recurrence after RP [17, 21, 22]. This evidence concerns the gene SLCO2B1 and posterior cortical atrophy.